Skip to the main content.

Cell and Gene Therapy Series: Part 5 - Future ATMP Manufacturing Paradigms: Lessons From History

Dr. Dave Seaward : 15 March 2022

Cell and Gene Therapy Series: Part 5 - Future ATMP Manufacturing Paradigms: Lessons From History

We dive back over 100 years as we look at the history of the pharmaceutical industry to see what lessons might be learnt for ATMP production.

This blog will also look the future of ATMP paradigms, taking lessons from the past.

Click here to read.
Mark Wilson - Navigating Innovation in a Slow-Moving Pharma Industry

Mark Wilson - Navigating Innovation in a Slow-Moving Pharma Industry

Georgia Lewis: 11 March 2026

Mark Wilson - Presentation at UK Pharmaceutical & MedTech Innovations event.ISPE UK Affiliate - 12/2/2026 Listening to Mark’s reflections on his 20...

Read More
Optimising Cryovial Filling and Cryopreservation for Reliable Cell Functionality

Optimising Cryovial Filling and Cryopreservation for Reliable Cell Functionality

3P innovation: 10 March 2026

An Integrated Equipment Workflow for Consistent Post-Thaw Viability and Function Recovery

Read More
The challenges of developing combination products: Regulatory complexity and the case for a holistic development strategy

The challenges of developing combination products: Regulatory complexity and the case for a holistic development strategy

Dr. Dave Seaward: 15 February 2026

Drug–device combination products are becoming a defining feature of modern pharmaceutical portfolios, shaping how therapies differentiate, extend...

Read More